Page 142 - Read Online
P. 142

Guerra et al. J Transl Genet Genom 2019;3:9. I  https://doi.org/10.20517/jtgg.2018.03                                               Page 9 of 31

                Laryngeal Dystonia [44,48]  Hyperk  TOR1A  Torsin 1A                            9q34
                                               HPCA     Hippocalcin                             1p35
                                               TUBB4    Tubulin beta 4A                         19p13
                                               THAP1    Thao domain-containing protein 1        8p11
                                               DYT7     Dystonia 7                              18p
                                               DYT13    Dystonia 13                             1p36
                                               CIZ1     CDKN1A-interacting zinc finger protein 1  9q34
                                               ANO3     Anoctamin 3                             11p14
                                               GNAL     Guanine nucleotide-binding protein, alpha activity polypeptide,  18p11
                                                        olfactory type
                Tourette Syndrome  [59-61]  Hyperk  IMMP2L  Inner mitocondrial membranepeptidase subunit 2  7q31.1
                                               PNKD     Myofibrillogenesis regulator 1          2q35
                                               CNTNAP2  Contactin Associated Protein 2          7q35-q36
                Huntington Disease  [62-64]  Hyperk  HTT  Huntingtin                            9p16.3
                                               FOXP1    Forkhead box 1                          3p13
                Essential Tremor   [67]  Hyperk  DRD3   Dopamine receptor D3                    3q13.31
                                               FUS      Fused in sarcoma                        16p11-2
                                               TENM4    Teneurin transmembrane protein 4        11q14.4
                                               ETM2     Essential tremor 2 hereditary           22p5-p22
                                               ETM3     Essential tremor 3 hereditary           6p23

               Hyperk: hyperkinetic; Hypok: hypokinetic

               early speech therapy intervention improves the patient’s ability to communicate . Concerning Prader Willi
                                                                                  [18]
               syndrome, anatomical alterations in the mouth and larynx, and the underlying brain dysfunction, contribute
               to alterations in speech and language. Oral motor function, tone level and resonance are altered, with a
                                       [19]
               characteristic flaccid pattern . A summary of the main genes involved in both conditions are included in
               Table 2.

               Ataxic dysarthria
               Ataxic dysarthria relates to disorders that alter the cerebellar pathway. It is characterized by interruptions
                                                                                                   [12]
               in the articulation of speech, irregularity in the intensity of the tone and marked vocal tension . This
               group includes hereditary ataxia. So far, reports have identified over 30 genotypes. Hereditary ataxia may
               be progressive, such as spinocerebellar ataxia (SCA) and Friedreich’s ataxia (FRDA), or sporadic, such as
               episodic ataxia (EA). SPAX also refers to those ataxias that often have a prominent component of spasticity,
               thus changing the patient’s dysarthric characteristics .
                                                           [20]

               Trinucleotide expansion diseases relate to some hereditary ataxias, with mutations where repetitions of
               trinucleotides in certain genes or introns exceed the normal stable threshold that differs by gene, by unstable
               microsatellites that occur throughout all genomic sequences. This is the case of SCA1-7 and SCA17, where
               the repeated codon is CAG, which is the coding region for glutamine (Q), resulting in a polyglutamine
               (polyQ) tract. FRDA, SCA8, and SCA12 are other examples, but they do not code for glutamine and
                                           [21]
               categorize as non-PolyQ diseases .

               For those patients in whom the genetic screening tests for SCA1, 2, 3, 6, 7, and FRDA are negative (The most
               frequent ataxias), the study of small pathogenic intragenic variants for PRKCG, TTBK2, SETX, SPTBN2,
               SACS, MRE11, KCNC3 and DARS2 might be useful, as these are more prevalent secondary groups. It is
               especially helpful in patients with progressive onset disorders in childhood or adolescence and/or with a
                           [20]
               family history . Several studies assessed the phenotypic particularities of disorders that generate ataxic
               dysarthria [22-24] . Clinical characterization of the voice helps to discriminate between different types of ataxia
                                    [24]
               and guides vocal therapy .
               Friedreich ataxia (FRDA): Friedreich ataxia (FRDA gene, locus 9q21.11) is the most common progressive
               hereditary ataxia, with an autosomal recessive inheritance pattern. It produces degeneration, among other
               structures, of white matter cerebellar areas and afferent pathways of different brainstem nuclei. Speech
   137   138   139   140   141   142   143   144   145   146   147